Cymbalta, the drug manufactured by Eli Lilly is now legally approved to be marketed in Europe.
The drug is used as treatment for generalized anxiety disorder where the victim experiences a great deal of worry and anxiety. Anxiety disorder is known to afflict 9 million people in Europe.
The drug had earlier been approved for use to alleviate severe depressive disorder and neuropathic pain.
Sales for this drug had touched $2.1 billion in 2007. Shares of Eli Lilly has shown progress, up by 1.7%.